- Home
- INZY vs MTRX Comparison
INZY vs MTRX Comparison
Compare INZY & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- MTRX
- Stock Information
- Founded
- INZY 2015
- MTRX 1984
- Country
- INZY United States
- MTRX United States
- Employees
- INZY N/A
- MTRX N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- MTRX Engineering & Construction
- Sector
- INZY Health Care
- MTRX Consumer Discretionary
- Exchange
- INZY Nasdaq
- MTRX Nasdaq
- Market Cap
- INZY 321.4M
- MTRX 293.9M
- IPO Year
- INZY 2020
- MTRX 1990
- Fundamental
- Price
- INZY $3.13
- MTRX $12.52
- Analyst Decision
- INZY Strong Buy
- MTRX Strong Buy
- Analyst Count
- INZY 7
- MTRX 1
- Target Price
- INZY $16.14
- MTRX $18.00
- AVG Volume (30 Days)
- INZY 313.3K
- MTRX 124.4K
- Earning Date
- INZY 11-05-2024
- MTRX 11-06-2024
- Dividend Yield
- INZY N/A
- MTRX N/A
- EPS Growth
- INZY N/A
- MTRX N/A
- EPS
- INZY N/A
- MTRX N/A
- Revenue
- INZY N/A
- MTRX $696,133,000.00
- Revenue This Year
- INZY N/A
- MTRX $28.10
- Revenue Next Year
- INZY N/A
- MTRX $13.85
- P/E Ratio
- INZY N/A
- MTRX N/A
- Revenue Growth
- INZY N/A
- MTRX N/A
- 52 Week Low
- INZY $3.08
- MTRX $8.61
- 52 Week High
- INZY $7.80
- MTRX $13.90
- Technical
- Relative Strength Index (RSI)
- INZY 19.15
- MTRX 58.74
- Support Level
- INZY $4.02
- MTRX $12.65
- Resistance Level
- INZY $4.74
- MTRX $13.24
- Average True Range (ATR)
- INZY 0.27
- MTRX 0.52
- MACD
- INZY -0.11
- MTRX 0.08
- Stochastic Oscillator
- INZY 2.65
- MTRX 64.63
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About MTRX Matrix Service Company
Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities and Storage and Terminal Solutions.